• Sanofi (redirect from Sanofi-Synthélabo)
    was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis...
    92 KB (8,853 words) - 02:47, 25 December 2024
  • Thumbnail for Hoechst AG
    Rhône-Poulenc S.A. in 1999. With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals...
    9 KB (759 words) - 12:54, 14 January 2025
  • Thumbnail for Metoclopramide
    on 10 May 2017. Retrieved 24 August 2016. Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Lesechos.fr. Les Echos. Archived...
    51 KB (3,886 words) - 03:32, 12 January 2025
  • Thumbnail for L'Oréal
    purchased Synthélabo in 1973 to pursue its ambitions in the pharmaceutical field. Synthélabo merged with Sanofi in 1999 to become Sanofi-Synthélabo. Sanofi-Synthélabo...
    77 KB (7,106 words) - 18:20, 19 January 2025
  • Hoechst AG to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third-largest pharmaceutical company in the...
    6 KB (553 words) - 12:41, 11 September 2024
  • 1999, two French pharmaceutical companies, Sanofi and Synthélabo, merged to form Sanofi-Synthélabo. Soon after the merger, the new company divested several...
    25 KB (2,149 words) - 14:21, 28 October 2024
  • Thumbnail for Sulpiride
    01425.x. PMID 19906028. S2CID 35544028. Conard D (17 October 1991). "Synthélabo rachète les laboratoires Delagrange". Les Echos. "Laboratoires Delagrange"...
    30 KB (2,751 words) - 03:40, 14 January 2025
  • Thumbnail for CAC 40
    fully automated trading system. CAC 5 consisted of Leroy-Somer, LVMH, Synthélabo, Eurocom and UCB. CAC 40's base value of 1,000 was set on 31 December...
    16 KB (1,075 words) - 13:35, 3 January 2025
  • Thumbnail for Frankfurt
    Rhône-Poulenc to become Aventis in 1999 and in 2004 Aventis merged with Sanofi-Synthélabo to become Sanofi-Aventis. In 2005, around 22,000 people worked at Industriepark...
    231 KB (21,171 words) - 22:37, 16 January 2025
  • Thumbnail for Zolpidem
    used in Europe starting in 1988 and was brought to market there by Synthelabo. Synthelabo and Searle collaborated to bring it to market in the US, and it...
    68 KB (6,620 words) - 19:06, 12 January 2025
  • Thumbnail for Antipsychotic
    Delagrange/Sanofi-Synthélabo Thioridazine Tricyclic/Phenothiazine Typical Melleril 1958 Novartis Tiapride Benzamide Disputed Tiapridal 1975 Sanofi-Synthélabo Tiotixene...
    213 KB (18,762 words) - 12:00, 15 January 2025
  • Thumbnail for Apotex Inc v Sanofi-Synthelabo Canada Inc
    Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements...
    8 KB (1,183 words) - 00:50, 20 November 2022
  • Thumbnail for Paul Hudson (businessman)
    v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...
    5 KB (242 words) - 18:03, 20 November 2024
  • Thumbnail for Nadroparin calcium
    molecular weight heparins (LMWHs). Nadroparin was developed by Sanofi-Synthélabo. Nadroparin is used in general and orthopedic surgery to prevent thromboembolic...
    4 KB (222 words) - 06:01, 31 December 2023
  • Sanofi-Aventis – Sanofi-Aventis Ltd Sanofi Pasteur – Sanofi Pasteur MSD Ltd Sanofi-Synthélabo – Sanofi-Aventis Ltd Schering-Plough – Schering-Plough Ltd Schwarz – Schwarz...
    8 KB (815 words) - 00:56, 9 July 2024
  • Thumbnail for Roussel Uclaf
    Rhône-Poulenc to form Aventis, which then merged in 2004 with Sanofi-Synthélabo to form Sanofi-Aventis, which was since renamed Sanofi. Hoechst Schering...
    22 KB (1,896 words) - 21:54, 16 October 2023
  • Thumbnail for IG Farben
    merging with Rhône-Poulenc to form Aventis, which later merged with Sanofi-Synthélabo to form Sanofi. Two years earlier, another part of Hoechst was sold in...
    76 KB (7,090 words) - 17:26, 15 January 2025
  • Thumbnail for Hydroxychloroquine
    for Oral Use. Prescribing Information". rlsnet.ru (in Russian). Sanofi-Synthelabo. Archived from the original on 16 August 2016. Retrieved 14 July 2016...
    37 KB (4,806 words) - 00:59, 14 January 2025
  • v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...
    5 KB (386 words) - 09:12, 5 May 2023
  • Thumbnail for Ergocalciferol
    brand names, including Deltalin (Eli Lilly and Company), Drisdol (Sanofi-Synthelabo), and Calcidol (Patrin Pharma).[citation needed] "Summary Basis of Decision...
    24 KB (1,996 words) - 02:02, 12 January 2025
  • Thumbnail for Tolgabide
    Tolgabide (INN; development code SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed. It is an analogue of progabide...
    2 KB (87 words) - 08:56, 9 September 2024
  • Thumbnail for Genzyme
    v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...
    22 KB (2,018 words) - 18:29, 20 October 2024
  • production facilities in Frankfurt. In 2004, this company merged with Sanofi-Synthélabo to form Sanofi-Aventis, which was renamed Sanofi in 2011. Sanofi, headquartered...
    8 KB (791 words) - 01:51, 4 February 2024
  • original on 11 October 2007. Retrieved 28 August 2015. Reuters "Sanofi-Synthelabo lands Aventis for $64 billion – Apr. 26, 2004". "MediaOne-AT&T deal pushes...
    324 KB (11,926 words) - 02:49, 10 January 2025
  • v t e Sanofi Predecessors Sanofi-Synthélabo Aventis Hoechst Rhône-Poulenc Cassella Roussel Uclaf Marion Merrell Dow CEOs Chris Viehbacher Olivier Brandicourt...
    16 KB (1,678 words) - 17:21, 26 August 2024
  • Thumbnail for Primidone
    Apo-Primidone, Liskantin (Germany, Desitin), Resimatil (Germany, Sanofi-Synthélabo GmbH), Mylepsinum (Germany, AWD.pharma GmbH & Co., KG)., and Sertan (Hungary...
    91 KB (6,952 words) - 03:32, 14 January 2025
  • Thumbnail for Alfuzosin
    19–25. doi:10.1021/jm00151a003. Philippe M. Manoury, US4315007 (1982 to Synthelabo SA); CA, 96, 162737e. Keshav Deo, et al. WO2009001369 (to Alembic Ltd...
    9 KB (710 words) - 00:19, 23 November 2024
  • Standard. 7 April 1997. Retrieved 28 May 2024. "Torrent exits JV with Sanofi-Synthelabo: Reuters". Rediff. Retrieved 28 May 2024. "Torrent to buy Pfizer group's...
    11 KB (877 words) - 05:14, 6 November 2024
  • Thumbnail for Stanozolol
    Pharmaceuticals Acquires Mebaral(R), Chemet(R), and Winstrol(R) From Sanofi-Synthelabo Inc". PRnewswire. 7 August 2003. "Press Release: GTCR Completes the Sale...
    36 KB (3,328 words) - 06:19, 14 January 2025
  • Thumbnail for Valproate
    (Sanofi S.R.L. Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis Finland)...
    80 KB (6,706 words) - 03:20, 12 January 2025